Purchase Order 75N91018P00464

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $97,997.20 on April 4, 2017, for maintenance services for a Delta Vision OMX instrument. The order is firm fixed price with no small business set-aside. Place of performance is Marlborough, Massachusetts. The ultimate completion date is April 3, 2022.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on June 7, 2018, with a ceiling value of $4,300.08 and ultimate completion date of June 14, 2019. The order is priced as firm fixed price with no set-aside. Place of performance is Marlborough, Massachusetts. The specific procurement details and commodity description are not provided in the source material.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $24,441.58 on April 24, 2018, to supply laboratory supplies. The order carries no small business set-aside. Performance occurs in Marlborough, Massachusetts. Ultimate completion is May 23, 2018. The contract uses firm fixed price terms.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $11,440 on March 8, 2018, with completion by March 27, 2019. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside applied. Specific scope of supply is not detailed in the award record.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on April 17, 2018, for $6,222.68 with an ultimate completion date of May 26, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. The specific goods or services procured are not described in the source documentation.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $39,505.00 on September 17, 2018, for the acquisition of an Amersham 680 RGB instrument. Work is performed in Marlborough, Massachusetts. The ultimate completion date is October 1, 2018. The order carries firm fixed price and no set-aside designation; it originated from a pre-solicitation opportunity posted September 12, 2018.</p>

<p>The National Cancer Institute issued a purchase order to Global Life Sciences Solutions USA LLC on June 19, 2019, for a DV SCMOS 4.2 camera upgrade for a DV Elite deconvolution system, valued at $27,753.99. Work is performed in Marlborough, Massachusetts. The order carries a firm fixed price and has an ultimate completion date of September 18, 2019. The procurement originated from a special notice posted May 21, 2019, with a due date of May 31, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $14,350 on December 5, 2019, for a service agreement covering scientific equipment. Place of performance is Bethesda, Maryland. The order carries a firm fixed price and has an ultimate completion date of December 2, 2020. No set-aside was used.</p>

<p>The National Cancer Institute issued a delivery order to Global Life Sciences Solutions USA LLC on May 13, 2026, for supply of an Amersham Typhoon IP biomolecular imager, with a ceiling value of $64,769.64.</p> <p>Place of performance is Marlborough, MA. Ultimate completion date is December 31, 2026. This is a firm fixed-price delivery order issued under the Multiple Award Schedule (MAS), with no small business set-aside.</p>

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed-price purchase order valued at $24,940 to Global Life Sciences Solutions USA LLC. The contract calls for the delivery of an imaging system and associated easy-to-use software for band analysis and quantification of protein and DNA gels. The products and services will support research activities across the Laboratory of Biochemistry and...